PTPI_OUT_1 [2025-04-01 12:03:00 -0400] 2377 Bytes | 649 tokens | Cum: 649 tkns (8.11% of 8k)
==========================================================================

Listen up, partner—it's 12:02:57 PM on Tue Apr 01, 2025 -0400, and I’m revved up about Petros Pharmaceuticals (PTPI), climbing from 0.0691 to 0.0929. This stock is buzzing big-time—do we have a hidden gem, or a flash in the pan? Help me sift through the data!

Here's the first list of news for Petros Pharmaceuticals:

C1 - Mar-20-25 09:15AM - Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications
C2 - Feb-25-25 09:20AM - Petros Pharmaceuticals' Proprietary Technology Demonstrates Positive Data in Pivotal Study
C3 - Feb-18-25 09:25AM - Petros Pharmaceuticals Announces Pricing of $9.6 Million Public Offering of Common Stock and Warrants
C4 - Jan-07-25 09:15AM - Petros Pharmaceuticals Strategically Positioned to Benefit as Technology Leader from Newly Approved FDA OTC Final Rules
C5 - Dec-19-24 09:15AM - Petros Pharmaceuticals Featured in 'New Era of Healthcare, AI, Data and Consumer Empowerment'
C6 - Dec-17-24 09:00AM - Proprietary Technology Addressing the Rx-to-OTC Switch Self-Care Market Valued at over $38 Billion annually
C7 - Oct-19-24 05:28PM - Petros Pharmaceuticals Amends Presidents Employment Terms
C8 - Sep-11-24 09:15AM - Petros Pharmaceuticals Executes Successful Initial Test for App Comprehension as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil)

Prior AI Reports for PTPI:
1. 2025-03-26 – Score: 10 – Target: 0.0962 – Highs: 0.2300 / 0.1248 / 0.10
companys-downward-spiral-continues-investor-confidence-shaken

(Note: Highs = Same day / 2nd day / 3rd day)

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Petros Pharmaceuticals (PTPI)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

PTPI_OUT_3 [2025-04-01 12:03:04 -0400] 1099 Bytes | 259 tokens | Cum: 910 tkns (11.38% of 8k)
==========================================================================

Showing C1 (chunk 1 of 14): C1:
**Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications**
Date: Mar-20-25 09:15AM
Source: (ACCESSWIRE)
URL: https://www.accesswire.com/viewarticle.aspx?id=1002696

The first and only All-in-one subscription platform offering
all of your PR Distribution and Media Outreach Tools in one
single solution.Monthly & Annual Subscriptions.

Find & create journalist lists with the most up to date database in the industry.

Personalize and customize your pitch for maximum engagement.

Discover your brand, industry, and competitor mentions.

The first and only All-in-one subscription platform that offers you the ability
to manage all of your IR communications needs from a single
source.Explore our IR subscriptions

Ensure your IR Site is accessible for your entire audience.

Experience seamless calls with our dedicated team

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

PTPI_OUT_5 [2025-04-01 12:03:04 -0400] 1039 Bytes | 290 tokens | Cum: 1261 tkns (15.76% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-27T09:56:50Z - Why Greenland Technologies Shares Are Trading Higher By Around 89%; Here Are 20 Stocks Moving Premar...
A2 - 2025-03-26T14:11:42Z - Nasdaq Down 1%; Dollar Tree To Sell Family Dollar Business For $1 Billion - Acrivon Therapeutics (NA...
A3 - 2025-03-26T09:00:09Z - Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - AquaBoun...
A4 - 2025-03-20T13:35:53Z - Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across ...
A5 - 2025-03-20T13:26:00Z - Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals to Partner with Renowned Big Data Provider to E...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

PTPI_OUT_7 [2025-04-01 12:03:09 -0400] 1098 Bytes | 303 tokens | Cum: 1566 tkns (19.57% of 8k)
==========================================================================

Showing A1 (chunk 1 of 4): A1:
**Why Greenland Technologies Shares Are Trading Higher By Around 89%; Here Are 20 Stocks Moving Premarket**Date: 2025-03-27Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/25/03/44509351/why-greenland-technologies-shares-are-trading-higher-by-around-89-here-are-20-stocks-moving-premarketEnter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter

Shares of Greenland Technologies Holding Corporation GTEC rose sharply in today's pre-market trading after the company reported a year-over-year increase in FY24 EPS results.

Greenland Technologies posted FY24 earnings of $1.03 per share, versus a year-ago loss of $1.20 per share. The company's revenues fell to $83.94 million from $90.33 million.

Greenland Technologies Holding shares jumped 89.3% to $2.44 in pre-market trading

Here are some other stocks

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

PTPI_OUT_9 [2025-04-01 12:03:09 -0400] 1030 Bytes | 313 tokens | Cum: 1969 tkns (24.61% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-04-02T17:23:42Z - Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
B2 - 2024-01-30T18:18:27Z - Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
B3 - 2024-01-30T12:52:14Z - Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
B4 - 2023-12-13T12:55:44Z - Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
B5 - 2023-10-04T12:03:28Z - Why Brooge Energy Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
B6 - 2023-07-13T12:12:35Z - Why Senmiao Technology Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

PTPI_OUT_11 [2025-04-01 12:03:16 -0400] 1102 Bytes | 315 tokens | Cum: 2286 tkns (28.57% of 8k)
==========================================================================

Showing B1 (chunk 1 of 3): B1:
**Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session**Date: Unknown DateSource: Unknown SourceURL: https://www.benzinga.com/news/24/04/38053729/why-stryve-foods-shares-are-trading-lower-by-around-25-here-are-other-stocks-moving-in-tuesdays-midShares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.
Stryve Foods posted adjusted loss of $1.90 per share, versus market estimates for a loss of $1.96 per share. The company’s sales came in at $2.887 million versus expectations of $5.009 million, according to data from Benzinga Pro.
Stryve Foods shares dipped 25.2% to $1.0965 on Tuesday.
Here are some other stocks moving in today's mid-day session.
Gainers

VivoPower International PLC (NASDAQ: VVPR) shares surged 315% to $6.10 after the company's Tembo subsidiary

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

PTPI_OUT_13 [2025-04-01 12:03:17 -0400] 1068 Bytes | 276 tokens | Cum: 2682 tkns (33.52% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-03-31 10-K ITEM 7. MGT DISC & ANALYSIS OF FIN COND & RESULTS OF OPER

Mgts Discussion and Analysis of Fin Cond and Results of Oper (MDA) is designed to provide a reader of Petros CONS financial statements with a narrative f...

S2 - 2025-02-21 8-K Item 1.01 Entry into a Material Definitive Agrmt

On February 17, 2025, Petros Pharmaceuticals, Inc. (the Company) entered into a securities purchase agreement (the Purchase Agrmt) with certain institutional and accredited investors (collectively, the Investors) for the ...

S3 - 2025-02-21 8-K Item 1.01 Entry into a Material Definitive Agrmt

On February 17, 2025, Petros Pharmaceuticals, Inc. (the Company) entered into a securities purchase agreement (the Purchase Agrmt) with certain institutional and accredited investors (collectively, the Investors) for the ...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

PTPI_OUT_15 [2025-04-01 12:03:22 -0400] 1098 Bytes | 232 tokens | Cum: 2916 tkns (36.45% of 8k)
==========================================================================

Showing S1 (chunk 1 of 6): S1:
ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Managements Discussion and Analysis of Financial Condition and Results of Operations (MDA) is designed to provide a reader of Petros consolidated financial statements with a narrative from the perspective of management on the Companys financial condition, results of operations, liquidity and certain other factors that may affect future results. In certain instances, parenthetical references are made to relevant sections of the Notes to Consolidated Financial Statements to direct the reader to a further detailed discussion. This section should be read in conjunction with the Consolidated Financial Statements and Supplementary Data included in this Annual Report on Form 10-K. This MDA contains forward-looking statements reflecting Petros current expectations, whose actual outcomes involve risk

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

PTPI_OUT_17 [2025-04-01 12:03:23 -0400] 1098 Bytes | 262 tokens | Cum: 3281 tkns (41.01% of 8k)
==========================================================================

Showing S1 (chunk 2 of 6): s and uncertainties. Actual results and the timing of events may differ materially from those stated in or implied by these forward-looking statements due to a number of factors, including those discussed in the sections entitled Risk Factors and Cautionary Statement Regarding Forward-Looking Statements contained in this Annual Report on Form 10-K.

Overview

Petros was incorporated in Delaware on May 14, 2020, for the purpose of effecting the transactions contemplated by that certain Agreement and Plan of Merger, dated as of May 17, 2020 (as amended, the Merger Agreement), by and between Petros, Neurotrope, Inc., a Nevada corporation (Neurotrope), Metuchen Pharmaceuticals LLC, a Delaware limited liability company (Metuchen), and certain subsidiaries of Petros and Neurotrope. Petros consists of wholly owned subsidiaries: Metuchen, Neurotrope, Timm Medical Technologies, Inc. (Timm Medic

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

PTPI_OUT_19 [2025-04-01 12:03:39 -0400] 4882 Bytes | 1419 tokens | Cum: 4702 tkns (58.77% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+--------------------+-----------------------+------------------------+-----------------------+
| Volume: 24,731,666 | Perf Month: -7.01% | Option/Short: No / Yes | Sales Y/Y TTM: - |
+--------------------+-----------------------+------------------------+-----------------------+
| Avg Volume: 35.49M | Perf Quarter: -73.55% | Short Float: 3.04% | ROE: - |
+--------------------+-----------------------+------------------------+-----------------------+
| Rel Volume: 1.82 | Index: - | Short Ratio: 0.02 | ROI: - |
+--------------------+-----------------------+------------------------+-----------------------+
| RSI (14): 45.96 | Market Cap: 2.78M | Short Interest: 0.75M | Sales Surprise: 0.01% |
+--------------------+-----------------------+------------------------+-----------------------+
| ATR (14): 0.03 | Shs Outstand: 29.93M | Beta: 2.09 | EPS Surprise: 0.00% |
+--------------------+-----------------------+------------------------+-----------------------+
| SMA20: 6.65% | Shs Float: 24.49M | Sales Q/Q: -20.94% | P/E: - |
+--------------------+-----------------------+------------------------+-----------------------+
| SMA50: -44.67% | Inst Own: 3.25% | Sales past 5Y: -20.76% | Earnings: - |
+--------------------+-----------------------+------------------------+-----------------------+
| SMA200: -70.09% | Insider Own: 18.16% | Employees: - | |
+--------------------+-----------------------+------------------------+-----------------------+
| Perf Week: 60.55% | Insider Trans: 0.00% | Debt/Eq: 2.32 | |
+--------------------+-----------------------+------------------------+-----------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

Inside Trans: Petros Pharmaceuticals, Inc. (PTPI) by Bernstein Bruce (Unknown Title) on 2025-02-19
- Common Stock: 300000 shares at $0 (D)

Inside Trans: Petros Pharmaceuticals, Inc. (PTPI) by Boctor Fady (See Remarks) on 2025-02-19
- Common Stock: 450000 shares at $0 (D)

Inside Trans: Petros Pharmaceuticals, Inc. (PTPI) by Silverman Joshua (Unknown Title) on 2025-02-19
- Common Stock: 1000000 shares at $0 (D)

Inside Trans: Petros Pharmaceuticals, Inc. (PTPI) by Arnold Mitchell (See Remarks) on 2025-02-19
- Common Stock: 150000 shares at $0 (D)

Inside Trans: Petros Pharmaceuticals, Inc. (PTPI) by WALKER WAYNE REMELL (Unknown Title) on 2025-02-19
- Common Stock: 150000 shares at $0 (D)

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 4022393.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -4727200.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 0.0913
Average Volume: 86626861.86
30-Day High: 0.135
30-Day Low: 0.0578

[Detailed Financials: Q3 2024]
- Total Assets: $20,693,630.0
- Total Liabilities: $17,576,521.0
- Total Equity: $3,115,711.0
- Current Assets: $10,724,480.0
- Current Liabilities: $12,562,104.0

[Income Statement: Q3 2024]
- Revenue: $1,576,366.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -0.53

[Cash Flow Statement: Q3 2024]
- Net Cash Flow: $-9,442,290.0

[Detailed Financials: Q2 2024]
- Total Assets: $25,169,274.0
- Total Liabilities: $15,983,229.0
- Total Equity: $8,070,283.0
- Current Assets: $13,979,045.0
- Current Liabilities: $9,976,345.0

[Income Statement: Q2 2024]
- Revenue: $1,421,471.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -0.37

[Cash Flow Statement: Q2 2024]
- Net Cash Flow: $0
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

PTPI_OUT_21 [2025-04-01 12:03:42 -0400] 676 Bytes | 167 tokens | Cum: 5110 tkns (63.88% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

PTPI_IN_23 [2025-04-01 12:03:43 -0400] 126 Bytes | 29 tokens | Cum: 5209 tkns (65.11% of 8k)
==========================================================================

====================================
[2025-04-01 12:03:43] # Analysis Completed
Elapsed Time: 45.99 seconds